Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide vs Fluticasone in EoE
NCT02019758Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2015
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of EPI-EE, fluticasone propionate in eosinophilic esophagitis (EoE), sponsored by University of North Carolina at Chapel Hill. Started Jan 2015; status: completed.
02
Drugs
EPI-EEfluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02019758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019758.